271 related articles for article (PubMed ID: 36351016)
1. Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments.
Chen J; Zhang P; Zhao Y; Zhao J; Wu X; Zhang R; Cha R; Yao Q; Gao Y
Sci Adv; 2022 Nov; 8(45):eadd2789. PubMed ID: 36351016
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
3.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
5. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
6. Discovery of New
Pan Z; Zhou C; Bai X; Wang F; Hong J; Fang JY; Huang Y; Sheng C
J Med Chem; 2023 Dec; 66(23):15699-15714. PubMed ID: 37983010
[TBL] [Abstract][Full Text] [Related]
7.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
8. The Fruits of
Lin LT; Shi YC; Choong CY; Tai CJ
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279421
[TBL] [Abstract][Full Text] [Related]
9.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum reduces METTL3-mediated m
Chen S; Zhang L; Li M; Zhang Y; Sun M; Wang L; Lin J; Cui Y; Chen Q; Jin C; Li X; Wang B; Chen H; Zhou T; Wang L; Hsu CH; Zhuo W
Nat Commun; 2022 Mar; 13(1):1248. PubMed ID: 35273176
[TBL] [Abstract][Full Text] [Related]
13.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
14. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
[TBL] [Abstract][Full Text] [Related]
16. Effect of a bacteriocin-producing
Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
[TBL] [Abstract][Full Text] [Related]
17. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness.
Hong XL; Yu TC; Huang XW; Wang JL; Sun TT; Yan TT; Zhou CB; Chen HM; Su WY; Du W; Xiong H
Br J Cancer; 2023 Jan; 128(2):363-374. PubMed ID: 36396820
[TBL] [Abstract][Full Text] [Related]
18. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
19. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
